SHINE Medical Technologies, Inc. is improving its process for manufacture of its no-carrier-added Lu-177 radioisotope product using a novel chelato…
Office of NEPA Policy and Compliance
September 8, 2022
minute read time
SHINE Medical Technologies, Inc. is improving its process for manufacture of its no-carrier-added Lu-177 radioisotope product using a novel chelator in the separation from the irradiated target.